Literature DB >> 33708221

Cartilage Oligomeric Matrix Protein Induced Arthritis-A New Model for Rheumatoid Arthritis in the C57BL/6 Mouse.

Yunjuan Zhao1,2, Vilma Urbonaviciute2, Bingze Xu2, Weiwei Cai2, Zeynep Sener2, Changrong Ge2, Rikard Holmdahl2.   

Abstract

The most commonly used strains in experimental research, including genetically modified strains, are C57BL/6 mice. However, so far, no reliable model for rheumatoid arthritis is available, mainly due to the restriction by the MHC class II haplotype H-2b. Collagen-induced arthritis (CIA) is the most widely used animal model of rheumatoid arthritis, but C57BL/6 strain is resistant to CIA because there is no collagen II peptide associated with H-2b. To establish a rheumatoid arthritis model in C57BL/6 mice, we immunized C57BL/6NJ (B6N) mice with human cartilage oligomeric matrix protein (COMP), which induced severe arthritis with high incidence, accompanied by a strong auto-antibody response. Native COMP was required, as denatured COMP lost its ability to induce arthritis in B6N mice. An immunodominant COMP peptide was identified as the key T cell epitope, with a perfect fit into the Ab class II peptide binding pocket. A critical amino acid in this peptide was found to be phenylalanine at position 95. Recombinant COMP mutated at position 95 (COMP_F95S) lost its ability to induce arthritis or a strong immune response in the B6N mice. In conclusion, A new model for RA has been established using C57BL/6 mice through immunization with COMP, which is dependent on a COMP specific peptide binding Ab, thus in similarity with CIA in Aq expressing strains.
Copyright © 2021 Zhao, Urbonaviciute, Xu, Cai, Sener, Ge and Holmdahl.

Entities:  

Keywords:  B cell epitope; C57BL/6 mice; T cell epitope; cartilage oligomeric matrix protein; rheumatoid arthritis

Year:  2021        PMID: 33708221      PMCID: PMC7940517          DOI: 10.3389/fimmu.2021.631249

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  33 in total

Review 1.  The pathogenesis of rheumatoid arthritis.

Authors:  Iain B McInnes; Georg Schett
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

2.  HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.

Authors:  J M Meyer; T I Evans; R E Small; T W Redford; J Han; R Singh; G Moxley
Journal:  J Rheumatol       Date:  1999-05       Impact factor: 4.666

3.  Peptide binding predictions for HLA DR, DP and DQ molecules.

Authors:  Peng Wang; John Sidney; Yohan Kim; Alessandro Sette; Ole Lund; Morten Nielsen; Bjoern Peters
Journal:  BMC Bioinformatics       Date:  2010-11-22       Impact factor: 3.169

4.  Association of pepsin with type II collagen (CII) breaks control of CII autoimmunity and triggers development of arthritis in rats.

Authors:  C Vingsbo; P Larsson; M Andersson; R Holmdahl
Journal:  Scand J Immunol       Date:  1993-03       Impact factor: 3.487

5.  Cartilage oligomeric matrix protein induction of chronic arthritis in mice.

Authors:  Stefan Carlsen; Kutty Selva Nandakumar; Johan Bäcklund; Jens Holmberg; Malin Hultqvist; Mikael Vestberg; Rikard Holmdahl
Journal:  Arthritis Rheum       Date:  2008-07

6.  Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis.

Authors:  U Brunsberg; K Gustafsson; L Jansson; E Michaëlsson; L Ahrlund-Richter; S Pettersson; R Mattsson; R Holmdahl
Journal:  Eur J Immunol       Date:  1994-07       Impact factor: 5.532

7.  Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis.

Authors:  V Malmström; E Michaëlsson; H Burkhardt; R Mattsson; E Vuorio; R Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

8.  Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage.

Authors:  Changrong Ge; Dongmei Tong; Bibo Liang; Erik Lönnblom; Nadine Schneider; Cecilia Hagert; Johan Viljanen; Burcu Ayoglu; Roma Stawikowska; Peter Nilsson; Gregg B Fields; Thomas Skogh; Alf Kastbom; Jan Kihlberg; Harald Burkhardt; Doreen Dobritzsch; Rikard Holmdahl
Journal:  JCI Insight       Date:  2017-07-06

9.  High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

Authors:  Steve Eyre; John Bowes; Dorothée Diogo; Annette Lee; Anne Barton; Paul Martin; Alexandra Zhernakova; Eli Stahl; Sebastien Viatte; Kate McAllister; Christopher I Amos; Leonid Padyukov; Rene E M Toes; Tom W J Huizinga; Cisca Wijmenga; Gosia Trynka; Lude Franke; Harm-Jan Westra; Lars Alfredsson; Xinli Hu; Cynthia Sandor; Paul I W de Bakker; Sonia Davila; Chiea Chuen Khor; Khai Koon Heng; Robert Andrews; Sarah Edkins; Sarah E Hunt; Cordelia Langford; Deborah Symmons; Pat Concannon; Suna Onengut-Gumuscu; Stephen S Rich; Panos Deloukas; Miguel A Gonzalez-Gay; Luis Rodriguez-Rodriguez; Lisbeth Ärlsetig; Javier Martin; Solbritt Rantapää-Dahlqvist; Robert M Plenge; Soumya Raychaudhuri; Lars Klareskog; Peter K Gregersen; Jane Worthington
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

Review 10.  MHC class II proteins and disease: a structural perspective.

Authors:  E Yvonne Jones; Lars Fugger; Jack L Strominger; Christian Siebold
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

View more
  2 in total

Review 1.  How to Model Rheumatoid Arthritis in Animals: From Rodents to Non-Human Primates.

Authors:  Ting Zhao; Zhaohu Xie; Yujiang Xi; Li Liu; Zhaofu Li; Dongdong Qin
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 2.  Cartilage Oligomeric Matrix Protein, Diseases, and Therapeutic Opportunities.

Authors:  Jiarui Cui; Jiaming Zhang
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.